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Abstract
Background: Studies have shown that complex structural variants (cxSVs) contribute to human genomic variation
and can cause Mendelian disease. We aimed to identify cxSVs relevant to Mendelian disease using short-read
whole-genome sequencing (WGS), resolve the precise variant configuration and investigate possible mechanisms
of cxSV formation.
Methods: We performed short-read WGS and analysis of breakpoint junctions to identify cxSVs in a cohort of 1324
undiagnosed rare disease patients. Long-read WGS and gene expression analysis were used to resolve one case.
Results: We identified three pathogenic cxSVs: a de novo duplication-inversion-inversion-deletion affecting ARID1B,
a de novo deletion-inversion-duplication affecting HNRNPU and a homozygous deletion-inversion-deletion affecting
CEP78. Additionally, a de novo duplication-inversion-duplication overlapping CDKL5 was resolved by long-read WGS
demonstrating the presence of both a disrupted and an intact copy of CDKL5 on the same allele, and gene expression
analysis showed both parental alleles of CDKL5 were expressed. Breakpoint analysis in all the cxSVs revealed both
microhomology and longer repetitive elements.
Conclusions: Our results corroborate that cxSVs cause Mendelian disease, and we recommend their consideration
during clinical investigations. We show that resolution of breakpoints can be critical to interpret pathogenicity and
present evidence of replication-based mechanisms in cxSV formation.
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Background
Structural variants (SVs) are a major source of variation in
the human genome and collectively account for more differ-
ences between individuals than single nucleotide variants
(SNVs) [1, 2]. SVs are categorised as canonical or complex
[3]. The canonical forms can be balanced or unbalanced and
comprise inversions, insertions, translocations, deletions and
duplications. More complex rearrangements are typically
composed of three or more breakpoint junctions and cannot
be characterised as a single canonical SV type. These are
known as non-canonical or complex SVs (cxSVs) [3, 4].
Several previous studies have reported clinically relevant
cxSVs in individuals with Mendelian disorders. For example,
a duplication-triplication-inversion-duplication was found at
theMECP2 and PLP1 loci in individuals with MECP2 dupli-
cation syndrome or Lubs syndrome (MIM: 300260) and
Pelizaeus-Merzbacher disease (MIM: 312080) [5, 6], and a
duplication-inversion-terminal deletion of chromosome 13
was present in foetuses with 13q deletion syndrome [7],
among others [8–10]. Recently, pathogenic cxSVs associated
with autism spectrum disorder and neuropsychiatric
disorders have also been reported [11, 12]. Whole-genome
sequencing (WGS) studies have shown that cxSVs are
considerably more abundant and diverse than had been
previously appreciated, representing an estimated 2% of
the SVs in the human genome, and each human genome
contains on average 14 cxSVs [11]. The presence of
multiple types of cxSVs has also been independently
observed in several other studies [5, 12–14]. Extreme
cases of cxSVs, such as chromothripsis, have also been
identified in both cancer cells and the germline and
involve hundreds of rearrangements often concerning
more than one chromosome [11, 15].
Nevertheless, cxSVs are not typically considered during
genomic analysis, largely due to technical challenges of
identification. Complex SVs have been reported in projects
such as the 1000 Genomes, but these primarily focused on
the canonical types [1, 16, 17]. With the rapid expansion of
high-throughput sequencing technologies including long-
read WGS, genome-wide characterisation of SVs with high
precision has been achieved [1], facilitating the study of
more complex forms of SVs.
Therefore, in the present study, we sought to investi-
gate the role of cxSVs in Mendelian disease by first iden-
tifying potentially clinically relevant cxSVs in a subset of
the NIHR BioResource project using short-read WGS,
second, resolving the variant configuration to base pair
level resolution and, third, investigating possible mecha-
nisms of cxSV formation by breakpoint analysis.
Methods
Cohort description
This cohort comprises 1324 individuals from the NIHR
BioResource research study, which performs WGS of
individuals with undiagnosed rare disorders. It is com-
posed of three different subprojects: 725 were in the
Inherited Retinal Disorders (IRD) project, 472 were in
the Neurological and Developmental Disorders (NDD)
project and 127 were in the Next Generation Children
(NGC) project, which performs diagnostic trio WGS of
individuals from Neonatal and Paediatric Intensive Care
Units.
Short-read WGS and variant identification
We performed short-read WGS and excluded the possi-
bility of pathogenic SNVs or indels, as part of the NIHR
BioResource project as previously described [18]. For the
NDD and IRD subprojects we restricted SNVs and indel
analysis to known disease-associated genes, which we
assembled from sources including OMIM, RetNet and
literature searches, then curated to ensure they comply
with previously described criteria [19]. The lists comprise
1423 genes (NDD) and 248 genes (IRD). For NGC partici-
pants, trio analysis focused on de novo and rare biallelic
variant discovery unrestricted by a gene list.
The first stage of cxSV identification was calling and
filtering canonical SVs. These initial calls comprise simple
canonical SVs, and those which were potentially individual
segments of cxSVs were then identified by clustering.
These canonical SVs were called by Canvas [20], which
identifies copy number gains and losses based on read
depth, and Manta [21], which calls translocations, dele-
tions, tandem duplications, insertions and inversions,
and is based on both paired read fragment spanning
and split read evidence. SVs were initially filtered to
keep only those that pass standard Illumina quality filters,
do not overlap previously reported CNVs in healthy cohorts
[22] and are rare (minor allele frequency < 0.01) in the
whole NIHR BioResource study (n = 9453) Schematic of
the workflow can be found in Additional file 1: Figure S1.
Identification of potentially clinically relevant cxSVs
To identify potentially clinically relevant cxSVs we first
identified putative cxSVs in the 1324 individuals by clus-
tering canonical SV calls from Canvas and Manta using
Bedtools cluster allowing a maximum distance between
calls of 1 Kb [23]. We then categorised the putative
cxSVs into different subtypes previously described [11].
Next, as the scope of this study was limited to the
identification of potentially clinically relevant cxSVs, we
performed strict post-processing on the list of putative
cxSVs. We excluded any for which visual inspection of
the reads in IGV suggested the cxSV was not real but an
artefact of a region of low sequencing quality and any in
a gene that was not consistent with both the expected
genotype and phenotype of the patient. We also filtered
out retrotransposons, which are miscalled as multiple
clustered intronic deletions, and dispersed duplications,
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which are frequently miscalled as an overlapping dele-
tion and tandem duplication [24].
Validation
Sanger sequencing of the PCR product of the breakpoints
was performed using standard protocols. Copy number
variable segments of cxSVs and regions of homozygosity
were confirmed using Illumina SNP genotyping array as
previously described [18], and/or CytoScan® 750 K Cyto-
genetics Solution microarray (Affymetrix).
To resolve the configuration of the cxSV in participant 4
(P4), we performed long-read WGS with Oxford Nanopore
Technologies (ONT). The sample was prepared using the
1D ligation library prep kit (SQK-LSK108), and genomic
libraries were sequenced on R9 flowcell. Read sequences
were extracted from base-called FAST5 files by albacore
(version 2.0.2) to generate FASTQ files and then aligned
against the GRCh37/hg19 human reference genome using
NGMLR (version 0.2.6) [25] and LAST (version 912) [26],
in order to compare results. Analysis was performed
using default parameters, and for LAST, we used first
last-train function to optimise alignment scoring. Variant
calling was performed with Sniffles [25] and NanoSV [27],
respectively.
RNA gene expression analysis of CDKL5 was as also
performed on P4 and both parents. RNA was extracted
from blood using the PAXgene Blood RNA Kit (QIAGEN)
and retro-transcribed using the High Capacity cDNA
Reverse Transcription Kit (Thermo Fisher Scientific).
We performed PCR amplification and Sanger sequencing
of the informative SNP rs35478150 (X:g.18638082A>C).
Breakpoint flanking sequence analysis
We analysed the sequence flanking each confirmed
breakpoint (+/− 150 bps) and manually identified micro-
homology. The percentage of repetitive sequence was
then calculated using RepeatMasker version open-4.0.7
(http://www.repeatmasker.org). In order to identify de
novo SNVs and indels at the breakpoint junctions,
SNV/indel calling and de novo filtering was performed
with Platypus (http://github.com/andyrimmer/Platypus)
for those participants for which parental WGS was
available (P1 and P4).
Results
Potentially clinically relevant cxSVs in four individuals
with Mendelian disease
We identified four individuals with potentially clinically
relevant cxSVs. Participant 1 (P1) presents a de novo
duplication-inversion-inversion-deletion encompassing
ARID1B (MIM: 135900) that causes Coffin-Siris syndrome
(CSS [MIM: 135900]). This individual was a 4-month-old
female who was born prematurely and presented with
characteristic features of CSS as a neonate. CSS is a
multiple malformation syndrome characterised by intellec-
tual disability, severe speech impairment, coarse facial fea-
tures, microcephaly, developmental delay and hypoplastic
nails of the fifth digits [28].
A large cxSV was identified on chromosome 6, com-
prising a 3.3Mb duplication, two inversions of 4.9 Kb
and 3.3Mb, and a 16.3Mb deletion (Fig. 1a; Table 1). A
total of 87 protein-coding genes were within the structural
variant boundaries (Additional file 2: Table S1), of which
21 have been previously described as disease-associated in
OMIM. The 16.3Mb deletion contains 72 genes, of which
only 6 have been reported as associated with autosomal
dominant disease or constrained for loss-of-function
(LOF) variation in ExAC [29] (Additional file 2: Table S1).
Of these 6, only ARID1B has been previously reported as
disease-associated with a LOF mechanism. Haploinsuffi-
ciency of ARID1B causes CSS, consistent with the pheno-
type of P1. We also looked at the 10 autosomal recessive
genes within the deletion and did not find a second likely
pathogenic variant in any. No disease-associated gene
that was present within the duplicated region had been
reported to be triplosensitive. Furthermore, the first
inversion and the 3′ breakpoint of the second inversion
were within CNKSR3 (MIM: 617476). However, CNKSR3
has not previously been associated with disease and is not
constrained for LOF variation in ExAC; thus, the effect of
this inversion on the phenotype remains unknown.
Although the LOF of ARID1B likely explains the pheno-
type of this individual, it is possible that other genes affected
by the cxSV might contribute to the phenotype. Examin-
ation of the parental origin of the hemizygous variants
in the deleted region confirmed that the cxSV occurred
on the paternal chromosome, consistent with previously
reported observations that ~ 80% of de novo mutations
are of paternal origin [30].
Participant 2 (P2) has a de novo deletion-inversion-du-
plication encompassing HNRNPU (MIM: 602869). This
individual is a 22-year-old male who presented at term
with hypotonia. All his early developmental milestones
were delayed, and he presented with tonic-clonic seizures
at 9months. His seizure disorder has been managed by
medication but has continued episodically into adulthood.
He also has significant intellectual disability, autism, and
limited speech and language, and MRI showed partial
agenesis of the corpus callosum and enlarged ventricles.
We identified a cxSV on chromosome 1, formed by a
1.2 Mb deletion and a 246 Kb duplication flanking an
inversion of 505 Kb (Fig. 1b; Table 1). This variant
encompassed eight genes (Additional file 2: Table S1),
of which two were previously associated with disease:
COX20 (MIM: 614698) and HNRNPU, both within the
deletion boundaries. Haploinsufficiency of COX20 was
not deemed likely to be pathogenic as variants in this
gene have an autosomal recessive mode of inheritance
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and result in a mitochondrial complex IV deficiency
(MIM: 220110), which is not consistent with the individ-
ual’s phenotype, and no second rare variant was identified.
However, HNRNPU is a highly constrained gene for
LOF variants, in which haploinsufficiency causes early
infantile epileptic encephalopathy (EIEE [MIM: 617391]).
A B
C D
Fig. 1 Four complex structural variants identified by genome sequencing. Plots show changes in coverage of short-read WGS (normalised depth
t score using CNView, n = 250) [48]. Schematic models show the possible sequences of mutational events leading to the formation of the
confirmed cxSVs, including putative intermediate derivative chromosomes where relevant. Sizes of fragments are approximately to scale where
possible. An extended version of this figure showing breakpoint junction sequences is provided in Additional file 1: Figure S5, and alternative
models for P4 are provided in Additional file 1: Figure S2. a A duplication-inversion-inversion-deletion causes Coffin-Siris syndrome in P1. b A
deletion-inversion-duplication causes intellectual disability and seizures in P2. c A deletion-inversion-deletion causes cone-rod dystrophy in P3. d
A duplication-inversion-duplication overlaps with CDKL5 in P4, who had neonatal hypoxic-ischaemic encephalopathy. Oxford Nanopore
Technology (ONT) long-read WGS confirms the presence of a disrupted (J2) and intact (J6) copy of the gene. Only paternally inherited reads
overlapping the junction breakpoints are shown
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Microdeletions of HNRNPU have been described in indi-
viduals with intellectual disability and other clinical fea-
tures, such as seizures, corpus callosum abnormalities and
microcephaly [31].
Participant 3 (P3), a 66-year-old male, presented with
a cone-rod dystrophy and hearing loss due to a homozy-
gous deletion-inversion-deletion overlapping CEP78 (MIM:
617110). Onset was in his fifth decade with central vision
loss, photophobia and nystagmus accompanied by progres-
sive hearing impairment, following a severe influenza-like
viral infection. Two homozygous deletions in chromosome
9 of nearly 6 and 10 Kb were found flanking an inversion
of 298 bp (Fig. 1c; Table 1). The second deletion intersects
with the first 5 exons of CEP78. Biallelic LOF variants
in this gene have been previously shown to cone-rod
dystrophy and hearing loss (MIM: 617236) [32]. Although
we could not perform segregation analysis due to lack of
parental DNA, it was observed to be within a copy
number neutral region of homozygosity that comprised
approximately Chr9:70984372-86933884.
Participant 4 (P4) presents a duplication-inversion-du-
plication overlapping CDKL5 (MIM: 300203) on chromo-
some X. This individual was a female term (41 + 1) neonate
who presented with foetal bradycardia. She was diagnosed
with hypoxic-ischemic encephalopathy grade 2, intrauterine
hypoxia, and perinatal asphyxia, with poor cord gases.
Hypothermia was induced after birth for 72 h to reduce
brain injury. WGS revealed a de novo duplication-inversion-
duplication, with the respective sizes of 280 Kb, 458 Kb and
283 Kb (Fig. 1d; Table 1). The inversion 3′ breakpoint is in
intron 3 of 20 of CDKL5 (NM_003159). Heterozygous rare
variants in X-linked CDKL5 in females cause EIEE, severe
intellectual disability and Rett-like features (MIM: 300672).
There are three other genes within the boundaries of
this cxSV, none of them disease-associated in OMIM
(Additional file 2: Table S1).
Accurate resolution of variant configuration is necessary
for interpretation of pathogenicity
For each of the four cases, we validated each breakpoint
in order to resolve the variant configuration to base pair
level resolution. For P1, P2 and P3, all novel junctions
were confirmed by Sanger sequencing, and all copy
number changes were confirmed by microarrays that
were performed concurrently with the WGS (Fig. 1a–c).
No alternative pathogenic SNVs, indels or canonical SVs
were identified, and the cxSVs were absent in our internal
cohort of 9453 genomes, ClinVar or DECIPHER. The
cxSVs in P1, P2 and P3 were therefore classified as patho-
genic according to the ACMG guidelines [33].
Resolving the configuration of the cxSV in P4 was
more challenging because the SV calls from short-read
WGS were consistent with multiple possible configurations
(Additional file 1: Figure S2). Importantly, in two of the
possible configurations, there is an intact copy of CDKL5
on the non-reference allele, in addition to the disrupted
copy (Additional file 1: Figure S2A–B), whereas in
others there is no intact copy of CDKL5 (Additional file 1:
Figure S2C–D). Therefore, resolving the configuration
was essential for the interpretation of the pathogenicity
of this variant. We attempted PCR amplification over
the predicted new formed breakpoint junctions and
could only amplify one supporting the disrupted
CDKL5, due to repetitive sequence around the other
breakpoints. Both duplications were confirmed by
microarray.
In order to resolve the configuration, we performed
long-read WGS of P4 using ONT. We obtained a median
read length of 8136 bp (Additional file 1: Figure S3A), 56%
of the genome was covered with a minimum coverage of
3x (Additional file 1: Figure S3B), and around 97% of the
reads mapped to the human genome (GRCh37/hg19). All
the breakpoints of the cxSV were covered by at least four
reads. Coverage was insufficient to resolve the cxSV using
long-read SV calling algorithms such as Sniffles [25] or
NanoSV [27] (for which a minimum coverage of 10x is
recommended). In lieu of this, we manually reviewed the
split long reads across the cxSV junction breakpoints.
Eight of the reads that covered the cxSV breakpoints were
identified as inherited from the paternal chromosome,
either by SNP phasing (Fig. 1d, J2, J3, J4 and J6) or by
indirect phasing based on the assumption that breakpoint
junctions occur on the same allele (Fig. 1d, J5). Therefore,
ONT sequencing allowed us to identify two reads
supporting the junction that was initially not possible
to confirm by Sanger sequencing (J5) due to repetitive
sequences. By phasing analysis, we were also able to
identify three reads supporting an intact copy of CDKL5
in the allele inherited from the father (Fig. 1d, J6), con-
firming that the cxSV harbours an intact copy of CDKL5.
Two possible configurations remain (Additional file 1:
Figure S2A–B), both of which have been proposed previ-
ously [12, 34]. These are indistinguishable by short-read
sequencing technology because the breakpoint junctions
are identical, or even by long reads unless all junctions
are crossed in the same molecule. Only one of these
possible configurations is represented in Fig. 1d and
Table 1 for clarity.
We performed RNA expression analysis (Sanger se-
quencing of one informative SNP using cDNA) and
demonstrated biparental allele expression of CDKL5 in
the child (Additional file 1: Figure S4). This further
supports the presence of an intact copy of CDKL5 on
the paternal allele and suggests that regulation of CDKL5
is probably not perturbed by the nearby cxSV. This variant
was classified as VUS. The child is currently 1 year old
and developmentally normal with no seizures, but remains
under ongoing follow-up.
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Microhomology and repetitive elements occur in
conjunction at cxSV breakpoint junctions
Mutational signatures around novel breakpoint junctions
of SVs can yield insights into the mechanisms by which
they were formed. Therefore, we analysed the sequences
of all of the novel breakpoint junctions. It has previously
been reported that DNA replication-based mechanisms
such as microhomology-mediated break-induced replica-
tion (MMBIR) or fork stalling and template switching
(FoSTeS) are likely to be the primary mechanism respon-
sible for the formation of cxSVs [3, 4, 35–37]. Our data
overall support this as there is microhomology of at least 3
bp in all of the eight novel breakpoint junctions in the four
individuals (Additional file 1: Figure S5 and Additional file 2:
Table S2). We also observe in P2 the insertion of two
sequences of 5 and 48 bp in J1 and J3 junctions, and the
insertion in P4 of a 100 bp Alu sequence in J2 junction.
It has been previously suggested that Alu elements could
facilitate template switching and annealing via homology
between replication forks [37].
Additional evaluation of the breakpoint sequences with
RepeatMasker also identified longer repetitive elements
in all of the individuals (Table 2 and Additional file 1:
Figure S5). In P1, we found that sequence flanking two
of the breakpoints had high similarity to SINE sequences
(ERVL-MaLRs), one with LINE sequences (L2) and one
with DNA/hAT-Charlie (MER3) sequences (Table 1); in
P2, we noted that sequence flanking three of the break-
points had similarity to SINE sequences (Alu and MIR); in
P3, sequences surrounding all the breakpoints presented
high similarity to LINEs; and in P4, one of the breakpoints
had similarity to SINE/Alu sequences.
A recent study showed that a high proportion of Alu-
mediated SVs contain a hybrid Alu element in the deriva-
tive chromosome [34]. However, we do not observe these
in our study. Studies have also shown that due to the
error-prone nature of replication-based mechanisms of
cxSV formation, de novo SNVs and indels can occur
concomitantly to cxSVs [38]. Thus, we looked for de novo
SNVs or indels in 1 Kb regions around each novel break-
point junction in those individuals for which parental
WGS data was available (P1 and P4), and there were none.
For P2 and P3, we considered all rare SNVs and indels in
those regions and did not identify any.
Discussion
In the present study, we aimed to identify cxSVs relevant
to Mendelian disease using short-read WGS, to resolve the
precise variant configurations and to investigate possible
mechanisms of cxSV formation. We have presented three
individuals with pathogenic cxSVs and one with an inter-
esting cxSV of unknown significance. We showed that pre-
cise resolution of variant configuration can be essential for
interpreting pathogenicity and presented evidence of both
DNA replication based and homologous recombination
mechanisms of formation.
Here, we highlight the role of cxSVs as a cause of Men-
delian disease. However, cxSVs are not typically considered
Table 2 Repetitive elements associated with cxSV reference breakpoints in the four participants
Participant Breakpointa Coordinate of breakpoint Repetitive elements
P1 A3′-B5′ 6:151443332 91% LTR/ERVL-MaLR
B3′-C5′ 6:154768570 32% DNA/hAT-Charlie
C3′-D5′ 6:154774047 75% LTR/ERVL-MaLR
D3′-E5′ 6:154778901 26% LINE/L2
E3′-F5′ 6:154778992 –
P2 A3′-B5′ 1:244867200 70% SINE/Alu
B3′-C5′ 1:246064238 –
C3′-D5′ 1:246569871 45% SINE/MIR
D3′-E5′ 1:246816211 88% SINE/Alu
P3 A3′-B5′ 9:80843698 82% LINE/L1 and 14% SINE/Alu
B3′-C5′ 9:80849462 59% LINE/L1
C3′-D5′ 9:80849760 63% LINE/L1
D3′-E5′ 9:80859678 86% LINE/L1
P4 A3′-B5′ X:17793009 –
B3′-C5′ X:18074005 –
C3′-D5′ X:18248955 41% SINE/Alu
D3′-E5′ X:18532312 –
aRefers to genomic segments as shown in Fig. 1. Repetitive elements, identified using RepeatMasker, represent the percentage of repetitive sequence for a 300 bp
region of reference sequence flanking the breakpoint, as specified element: class/family
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in analysis pipelines, in part due to the technical and analyt-
ical challenges around identification and interpretation, and
when there is an associated deletion or duplication detected
by microarray further analysis is rarely performed. There-
fore, when not included in analyses, the full scope of
genome-wide structural variation is overlooked. In this
study, 0.2% (3/1324) of Mendelian disease cases were
caused by cxSV. This compares to approximately 5–20% of
individuals with Mendelian disorders who have a clinically
relevant canonical SV [18, 39, 40]. However, 0.2% is likely
to be an underestimate because short-read WGS has
limited power to resolve cxSVs and because our workflow
was designed to maximise specificity.
There are several technologies available for the identi-
fication of cxSVs, including short-read WGS, long-read
WGS, long insert WGS (liWGS) and microarrays, each
with strengths and limitations. This study demonstrates
the potential of short-read WGS to identify clinically
relevant cxSVs. An advantage of this is that it is a more
commonly used technology than some of the other
options and does not necessitate using a different technol-
ogy specifically to identify cxSVs. The main limitation is that
at repetitive regions mapping and variant calling algorithms
have lower sensitivity. This is particularly problematic given
that cxSVs are more likely to occur in repetitive regions.
These limitations may now be addressed by long-read
sequencing technologies such as Nanopore, either in
combination with another technology as in this study
or as a first line approach. These have the advantage of
reads of 10–100 Kb allowing for more accurate mapping
particularly over repetitive regions and facilitating phasing
[27]. Various other studies have already demonstrated the
power of long-read WGS to detect SVs and cxSVs [25, 27,
41, 42]. However, the limitations are that coverage is lower
and error rate is higher than short-read WGS. For these
reasons, it is unlikely that, in our case, these variants
would have been identified from long-read data alone
without prior knowledge of the region of interest. A third
possible method to identify complex rearrangements is
liWGS, which has been successfully employed to detect
cxSVs in other studies, and has the advantage over short-
read WGS of improved mapping particularly over repetitive
regions due to the large fragments, but has a lower reso-
lution of ~ 5 Kb [11–13].
The segments of cxSVs that have copy number
changes could in some cases be detected by microarray.
These have the advantage of low cost, and that they are
already the first-line test in many cases. However, they
do not allow precise resolution of breakpoints and they
would also miss inversions and those cxSVs where there is
no CNV change. Importantly, a routinely pre-screening by
microarray could potentially identify a high number of
cxSVs. Actually, it has been reported that 7.6% of all rare
duplications detected by microarray are part of a complex
rearrangement [12]. However, it is likely that many ‘canon-
ical CNVs’ detected by microarray are actually misclassi-
fied cxSVs, in part due to the impossibility for detecting
inversions by microarray, since inversions are involved in
84.8% of cxSVs [11]. In this study, the copy number
changes of all four cxSVs were confirmed by microarrays.
Our experience with P4, whose cxSV intersects CDKL5,
demonstrates that understanding the precise configuration
of a cxSV can be essential for interpreting the patho-
genicity of the variant, especially if the gene of interest
is disrupted by a duplication or inversion rather than a
deletion. The impact of a deletion on the function of
affected genes is generally assumed to be LOF. However,
the consequence of a duplication can be uncertain and
depends on precisely how the variant rearranges the gene,
as well as gene-specific factors such as dosage sensitivity.
Furthermore, duplications intersecting regulatory regions
can result in a different phenotype from variants within
the gene itself [43].
Investigating cxSVs in our cohort identified previously
reported subclasses (delINVdup, delINVdel and dupINVdup
in P2, P3 and P4, respectively), as well as a dupINVinvDEL
in P1 [11]. One of the limitations of our study is that certain
subclasses of cxSVs such as chromothripsis and those
formed by nested rather than chained breakpoints would be
excluded by our filtering and clustering method. Our
method was designed specifically to identify possibly patho-
genic variants in Mendelian disease, and thus was optimised
to maximise specificity, at the cost of sensitivity and
scalability. Therefore, while a detailed, sensitive, large-
scale assessment of the role of cxSVs in Mendelian disease
would be valuable, this is beyond the scope of the present
study. Even when a putative cxSVs is identified, sometimes
it is not straightforward to define them because the dis-
tinction between canonical SVs, cxSVs and chromoana-
genesis can be unclear [35, 38]. It is therefore perhaps
appropriate to consider types of human genomic variation
as a continuum rather than discrete classes, progressing
from SNVs (that typically cause the least disruption to the
genome), through indels, canonical SVs and cxSVs to the
highly disruptive chromoanagenesis and aneuploidies.
The high frequency of microhomology observed at the
breakpoint junctions of the cxSVs in our study and the
presence of inserted sequence in three of them is consistent
with the hypothesis that replication-based mechanisms
such as FoSTeS/MMBIR are primarily responsible for the
formation of cxSVs [3, 4, 35–37]. However, we also find
longer repetitive elements including Alu elements in the
vicinity of breakpoint junctions in all of the cxSVs,
consistent with other studies [44, 45]. The exact role of
repetitive elements in SV/cxSV formation is currently
unclear. Repetitive elements have classically been seen
as signatures of recombination-based mechanisms such
as non-allelic homologous recombination, which is a
Sanchis-Juan et al. Genome Medicine           (2018) 10:95 Page 8 of 10
well-known mechanism of formation of recurrent SVs
[4, 44]. This could suggest that recombination-based
and replication-based mutational mechanisms might
together mediate the formation of non-recurrent cxSVs.
However, it is more likely that repetitive elements facilitate
replication-based SV/cxSV formation by, for example,
providing the requisite microhomology islands or increas-
ing the susceptibility of the region to the formation of
secondary DNA structures that can cause replication fork
collapse [46, 47].
Conclusions
Our work demonstrates that cxSVs contribute to rare
Mendelian disorders, and provides insight into identifying
and resolving both the conformation and the mechanism
of formation of cxSVs by using short and long-read WGS.
We demonstrate that understanding the precise configur-
ation can be essential for interpreting the pathogenicity
of cxSVs. We suggest that cxSVs should be included
into research and clinical diagnosis and considered
when screening SVs in the human genome. Further
detailed characterisation of cxSVs in large-scale WGS
studies will be essential for further unveiling the com-
plex architecture of cxSVs and determining accurate
population frequencies.
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